Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_06043 | 3 | 0.06 | Mlig455_056332 | Neo: - Age: - |
Mlig455_056332 {REF} {Length: 356} {NoTransDecoderORF} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | - | - | - | - | |
RegionR2 | - | - | - | - | |
RegionR3 | - | - | - | - | |
RegionR4 | - | - | - | - | |
RegionR5 | - | - | - | - | |
RegionR6 | - | - | - | - | |
RegionR7 | - | - | - | - | |
RegionR8 | - | - | - | - |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | - | - | - | - | |
RegenerationR2 | - | - | - | - | |
RegenerationR3 | - | - | - | - | |
RegenerationR4 | - | - | - | - | |
RegenerationR5 | - | - | - | - | |
RegenerationR6 | - | - | - | - | |
RegenerationBL | - | - | - | - | |
RegenerationTP | - | - | - | - |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_06043 | 3 | 0.06 | Mlig455_056332 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_056332 {REF} {Length: 356} {NoTransDecoderORF} | |
2. | MligTC455_19225 | 26 | 0.54 | Mlig455_018507 | Neo: - Age: - |
SCNN1B | 0.986 | - | - | - | - | 0.986 | - | Mlig455_018507 {REF} {Length: 2590} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=142.8]} {Human: ENSG00000168447, SCNN1B, sodium channel epithelial 1 beta subunit, [Score=59.3, Expect=1e-08]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=60.8, Expect=1e-09]} {Smed: dd_Smed_v6_17245_0_1, dd_Smed_v6_17245_0_1, [Score=49.3, Expect=5e-06]} {RNA1509_52685} {RNA1310_32081} {RNA815_49764} |
3. | MligTC455_37761 | 12 | 0.26 | Mlig455_014845 | Neo: - Age: - |
0.982 | - | - | - | - | 0.982 | - | Mlig455_014845 {REF} {Length: 2142} {Pfam: CUB domain [PF00431.22, score=21.3]} {RNA1310_77188} | |
4. | MligTC455_38997 | 19 | 0.39 | Mlig455_066918 | Neo: - Age: - |
0.98 | - | - | - | - | 0.980 | - | Mlig455_066918 {REF} {Length: 1492} {NoTransDecoderORF} {RNA1509_2373} {RNA1310_20626} {RNA815_9142} | |
5. | MligTC455_15740 | 16 | 0.33 | Mlig455_035153 | Neo: - Age: - Region-enriched R5: 2.633/0.00195 Regeneration-downregulated R2: -2.853 Regeneration-depleted R2: -2.853 |
0.972 | - | - | - | - | 0.972 | - | Mlig455_035153 {REF} {Length: 1128} {Pfam: WSC domain [PF01822.21, score=54.4]; PAN domain [PF00024.28, score=25.4]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=52.8, Expect=1e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=55.1, Expect=1e-08]} {RNA1310_29927} {RNA815_55032} | |
6. | MligTC455_10605 | 2 | 0.04 | Mlig455_047968 | Neo: - Age: - |
0.97 | - | - | - | - | 0.970 | - | Mlig455_047968 {REF} {Length: 297} {NoTransDecoderORF} {RNA1509_34377} {RNA1310_100135} {RNA815_25886} | |
7. | MligTC455_19126 | 10 | 0.2 | Mlig455_009225 | Neo: - Age: - |
0.97 | - | - | - | - | 0.970 | - | Mlig455_009225 {REF} {Length: 1570} {Pfam: Galactosyltransferase [PF01762.23, score=21.4]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=50.4, Expect=1e-06]} {RNA1310_57689} {RNA815_57743} | |
8. | MligTC455_39100 | 62 | 1.29 | Mlig455_009476 | Neo: - Age: Down-Up-Down Region-enriched R4: 3.504/0.03677 |
CABP7 | 0.97 | - | - | - | - | 0.970 | - | Mlig455_009476 {REF} {Length: 960} {Pfam: EF hand [PF00036.34, score=45.6]; EF-hand domain [PF13405.8, score=35.6]; EF-hand domain pair [PF13499.8, score=30.4]; EF-hand domain pair [PF13833.8, score=29.2]; EF hand [PF13202.8, score=28.1]} {Human: ENSG00000100314, CABP7, calcium binding protein 7, [Score=46.6, Expect=1e-05]} {Mouse: ENSMUSG00000009075, Cabp7, calcium binding protein 7, [Score=46.6, Expect=8e-06]} {Celegans: WBGene00015264, B0563.7, Uncharacterized calcium-binding protein B0563.7, [Score=50.4, Expect=3e-07]} {Smed: dd_Smed_v6_13677_0_1, dd_Smed_v6_13677_0_1, [RH, Score=185, Expect=1e-57]} {RNA1509_25282} {RNA1310_29885.1} {RNA815_14774.1} |
9. | MligTC455_55494 | 2 | 0.05 | Mlig455_004790 | Neo: - Age: - |
0.97 | - | - | - | - | 0.970 | - | Mlig455_004790 {REF} {Length: 600} {Pfam: Receptor family ligand binding region [PF01094.30, score=64.3]; Periplasmic binding protein [PF13458.8, score=19.1]} | |
10. | MligTC455_14577 | 51 | 1.06 | Mlig455_024026, Mlig455_024091 | Neo: - Age: logFC(26M/2M)=-0.714 |
0.969 | - | - | - | - | 0.969 | - | Mlig455_024026 {REF} {Length: 243} {NoTransDecoderORF} {RNA1310_72624} Mlig455_024091 {REF} {Length: 2685} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=137.7]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=64.7, Expect=1e-10]} {RNA1310_28762} {RNA815_42177} |
|
11. | MligTC455_51200 | 66 | 1.37 | Mlig455_057090 | Neo: - Age: - |
0.968 | - | - | - | - | 0.968 | - | Mlig455_057090 {REF} {Length: 988} {RNA1310_63663} {RNA815_36272} | |
12. | MligTC455_00622 | 2 | 0.05 | Mlig455_047108 | Neo: - Age: - |
0.965 | - | - | - | - | 0.965 | - | Mlig455_047108 {REF} {Length: 64} {NoTransDecoderORF} | |
13. | MligTC455_39418 | 105 | 2.19 | Mlig455_060584 | Neo: - Age: logFC(26M/2M)=-0.365 |
0.964 | - | - | - | - | 0.964 | - | Mlig455_060584 {REF} {Length: 2959} {RNA1509_1853, RNA1509_19407} {RNA1310_3937, RNA1509_1853, RNA1509_19407} {RNA1509_1853, RNA1509_19407, RNA815_2591.1} | |
14. | MligTC455_07528 | 13 | 0.27 | Mlig455_064149 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_064149 {REF} {Length: 262} {NoTransDecoderORF} | |
15. | MligTC455_35325 | 26 | 0.54 | Mlig455_008452, Mlig455_031353, Mlig455_056519 | Neo: - Age: - |
HTR3A | 0.956 | - | - | - | - | 0.956 | - | Mlig455_008452 {REF} {Length: 1552} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010} Mlig455_031353 {REF} {Length: 1802} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=61.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=54.4]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=103, Expect=5e-25]; ENSG00000149305, HTR3B, 5-hydroxytryptamine receptor 3B, [Score=101, Expect=1e-24]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=100, Expect=4e-24]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=98.2, Expect=2e-23]; ENSMUSG00000008590, Htr3b, 5-hydroxytryptamine (serotonin) receptor 3B, [Score=96.3, Expect=7e-23]} {Dmel: FBgn0032151, nAChRalpha6, nicotinic Acetylcholine Receptor alpha6, [Score=93.6, Expect=6e-22]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=100, Expect=1e-24]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=90.5, Expect=5e-21]} {RNA1509_7752} {RNA1310_93708} {RNA815_49010} Mlig455_056519 {REF} {Length: 1867} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.9]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=26.8]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=97.4, Expect=2e-22]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=92.8, Expect=1e-20]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=92.8, Expect=6e-21]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=91.7, Expect=2e-20]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=90.9, Expect=3e-20]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=93.2, Expect=4e-21]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=98.2, Expect=6e-23]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=88.6, Expect=9e-20]} {RNA1509_53098} {RNA1310_93708} {RNA815_49010} |
16. | MligTC455_25410 | 47 | 0.97 | Mlig455_026185 | Neo: - Age: Up-Down-Down Region-enriched R2: 8.036/0.00469 |
0.954 | - | - | - | - | 0.954 | - | Mlig455_026185 {REF} {Length: 3002} {Pfam: Variant SH3 domain [PF07653.19, score=19.6]; Growth-arrest specific micro-tubule binding [PF13851.8, score=19.3]} {Mouse: ENSMUSG00000034156, Tspoap1, TSPO associated protein 1, [Score=54.7, Expect=6e-07]} {Smed: dd_Smed_v6_14584_0_1, dd_Smed_v6_14584_0_1, [Score=140, Expect=7e-35]} {RNA1509_45271} {RNA1310_5741} {RNA815_46868} | |
17. | MligTC455_35834 | 86 | 1.8 | Mlig455_011961 | Neo: - Age: - |
CES4A | 0.952 | - | - | - | - | 0.952 | - | Mlig455_011961 {REF} {Length: 3668} {Pfam: Carboxylesterase family [PF00135.30, score=101.0]} {Human: ENSG00000172824, CES4A, carboxylesterase 4A, [Score=79.0, Expect=9e-15]} {Mouse: ENSMUSG00000050097, Ces2b, carboxyesterase 2B, [Score=81.6, Expect=1e-15]; ENSMUSG00000061825, Ces2c, carboxylesterase 2C, [Score=81.6, Expect=1e-15]} {Dmel: FBgn0004108, Nrt, Neurotactin, [RH, Score=104, Expect=7e-23]} {Celegans: WBGene00019477, K07C11.4, Carboxylic ester hydrolase, [Score=77.0, Expect=2e-14]} {Smed: dd_Smed_v6_4800_0_2, dd_Smed_v6_4800_0_2, [Score=56.6, Expect=4e-08]} {RNA1310_8940} {RNA815_4325.1} |